• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Sarepta Therapeutics Inc

+ Add to Watchlist

SRPT:US

22.3600 USD 0.0100 0.04%

As of 20:10:00 ET on 08/19/2014.

Snapshot for Sarepta Therapeutics Inc (SRPT)

Open: 22.8000 Day's Range: 21.8800 - 22.8000 Volume: 481,413
Previous Close: 22.3500 52wk Range: 12.1200 - 55.6100 1-Yr Rtn: -30.77%

Stock Chart for SRPT

No chart data available.
  • SRPT:US 22.3300
  • 1D
  • 1M
  • 1Y
22.3500
Interactive SRPT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SRPT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -3.0169
Est. EPS (USD) (12/2014) -3.2820
Est. PEG Ratio -
Market Cap (M USD) 915.05
Shares Outstanding (M) 40.92
30 Day Average Volume 1,919,645
Price/Book (mrq) 3.0417
Price/Sale (ttm) 53.4405
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SRPT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SRPT

Sarepta Therapeutics, Inc. is a biopharmaceutical company focused on the discovery and development of unique RNA-based therapeutics for the treatment of both rare and infectious diseases. The Company offers its products to the medical industry in countries around the world.

John HodgmanInterim ChairmanChristopher N GarabedianPresident/CEO
Sandesh Mahatme "Sandy"Senior VP/CFO/Chief Acctg OfcrEdward M KayeSenior VP/Chief Medical Officer
More Company Profile & Key Executives for SRPT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil